Our Pricing

Understanding Tirzepatide Monthly Costs in the UK

Published on: June 03, 2026

Planning your tirzepatide monthly cost UK budget starts with understanding both the medication price and the clinical journey ahead. At Cured Pharmacy, Mounjaro (tirzepatide) is available from £124.99 per month with transparent upfront pricing, free clinical consultations under 3 minutes, and genuine UK-licensed medication delivered discreetly to your door.

What Influences Tirzepatide Monthly Cost UK?

Your tirzepatide monthly cost depends primarily on your prescribed maintenance dose, which typically ranges from 2.5mg to 15mg once weekly. Treatment follows a structured dose escalation schedule: most patients start at 2.5mg for four weeks, then increase gradually every four weeks until reaching their optimal therapeutic dose as determined by their prescriber [1].

At Cured Pharmacy, Mounjaro starts from £135.00 per month, with your final cost reflecting the dose prescribed after your free online consultation with a UK-registered clinician. Unlike some providers, we display pricing before you begin the consultation process, allowing you to budget accurately from the outset.

The SURPASS clinical trial programme demonstrated that higher tirzepatide doses produced greater weight reduction outcomes, with the 15mg dose achieving an average 22.5% body weight reduction over 72 weeks [1]. Your prescriber will balance clinical efficacy against tolerability when determining your maintenance dose, directly influencing your monthly treatment cost.

Mounjaro Treatment Timeline and Cost Planning

Most patients reach their maintenance dose between months 4-6, at which point your monthly cost stabilises. Clinical trials show that tirzepatide's maximum efficacy typically manifests between weeks 40-72, meaning effective budgeting should account for 9-12 months of continuous treatment [1][2].

UK prescribers recommend viewing tirzepatide as a medium to long-term intervention rather than a short-term solution. The SURMOUNT-1 trial demonstrated that participants who discontinued tirzepatide regained approximately 50% of their lost weight within one year, underscoring the importance of sustained treatment and realistic financial planning [3].

Dose Escalation Phase (Months 1-4)

The initial titration period involves four dose increases over approximately 16-20 weeks. You'll begin at 2.5mg weekly, progressing through 5mg, 7.5mg, and 10mg before potentially reaching 12.5mg or 15mg if clinically appropriate [2]. This gradual escalation minimises gastrointestinal side effects whilst allowing your body to adapt to tirzepatide's appetite-suppressing effects.

During this phase, your monthly cost remains consistent as each pen contains four weekly doses at your current strength. Planning for at least four months of treatment allows realistic budgeting for the period when most patients begin experiencing significant weight reduction.

Comparing Tirzepatide Monthly Cost UK Across Treatment Options

Tirzepatide represents the newest generation of weight loss medication licensed by the MHRA, offering dual GIP/GLP-1 receptor agonism compared to older single-pathway treatments. When evaluating monthly costs, consider both the financial investment and the clinical outcomes demonstrated in head-to-head trials.

The SURPASS-2 trial directly compared tirzepatide against semaglutide 1mg (the active ingredient in Wegovy), showing that tirzepatide 15mg produced superior weight reduction: 12.4kg versus 6.2kg at 40 weeks [4]. Whilst tirzepatide carries a higher monthly cost than some alternatives, the enhanced efficacy may represent better value for patients seeking maximum weight reduction outcomes.

At Cured Pharmacy, our clinical team assesses your medical history, weight loss goals, previous treatment responses, and budget considerations during your free consultation. This personalised approach ensures you receive the most appropriate treatment rather than defaulting to the lowest-cost option, which may prove less effective for your individual circumstances.

Hidden Costs to Consider When Budgeting

Delivery costs represent another variable that affects your true monthly expenditure. Cured Pharmacy includes discreet UK delivery in our quoted prices, with next-day delivery options available when you need treatment urgently. Always verify whether advertised prices include delivery before comparing providers.

Some patients also budget for complementary support such as nutritional guidance or fitness programmes to maximise their tirzepatide results. Whilst not medically necessary, lifestyle modifications enhance treatment outcomes: SURPASS trial participants followed a reduced-calorie diet and increased physical activity alongside medication [1]. Factor these optional costs into your overall weight loss budget if you plan to pursue comprehensive lifestyle changes.

Consultation and Monitoring Fees

At Cured Pharmacy, your initial online consultation and all follow-up prescriber reviews are included at no additional charge. Some providers charge separate consultation fees ranging from £135.00-40 per assessment, which can significantly increase your effective monthly cost over a 12-month treatment period.

Our UK-registered clinical team conducts regular medication reviews as part of your ongoing care, ensuring tirzepatide remains clinically appropriate as your weight reduces. These reviews are built into our transparent pricing structure rather than appearing as unexpected additional charges.

How to Reduce Your Tirzepatide Monthly Cost

Purchasing multiple months' supply when clinically appropriate can reduce per-month costs at some pharmacies, though prescribers typically limit initial prescriptions to one or two months whilst assessing tolerability. Once you've established tirzepatide suits you, discuss longer prescription durations with your clinician during follow-up consultations.

At Cured Pharmacy, we guarantee the lowest prices in the UK for genuine, licensed medications. If you find a lower price elsewhere for the same product from a UK-registered pharmacy, we'll match it. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees our pricing strategy to ensure patients access affordable treatment without compromising on quality or safety.

Consider whether you genuinely need the highest tirzepatide dose or whether a lower maintenance dose achieves your clinical goals. Some patients reach their target weight on 10mg or 12.5mg weekly rather than progressing to 15mg, reducing monthly costs whilst maintaining therapeutic benefits. Your prescriber will review your response at each consultation and adjust dosing accordingly.

Is Tirzepatide Worth the Monthly Investment?

Quality of life improvements reported in tirzepatide trials included enhanced mobility, reduced joint pain, improved sleep quality, and better psychological wellbeing [3]. Whilst these benefits don't appear on a pharmacy invoice, they represent genuine value that many patients consider when budgeting for treatment.

At Cured Pharmacy, our clinical team takes a holistic view of treatment value, discussing both financial costs and potential health benefits during your consultation. We're committed to helping UK patients access effective weight loss treatment through transparent pricing, genuine medications, and expert pharmaceutical care from our GPhC-registered team.

Clinical Evidence for Cost-Effectiveness

When evaluating tirzepatide's cost, consider the health conditions associated with obesity that the medication may help prevent or improve. The SURPASS trials demonstrated significant improvements in cardiovascular risk markers including blood pressure, lipid profiles, and inflammatory markers alongside weight reduction [1][2].

Patients with type 2 diabetes in the SURPASS programme achieved HbA1c reductions of up to 2.4% on tirzepatide 15mg, often allowing reduction or discontinuation of other diabetes medications [2]. The cost savings from reduced medication burden and fewer obesity-related health complications may offset tirzepatide's monthly price over time.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
3. Aronne, L. J., et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA, 331(1), 38–48. https://doi.org/10.1001/jama.2023.24945 [accessed 13 August 2026]
4. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Tirzepatide is a prescription-only medicine licensed by the MHRA for weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities, alongside a reduced-calorie diet and increased physical activity. Individual results may vary, and treatment outcomes depend on multiple factors including adherence, lifestyle modifications, and individual metabolic response.